Nanoformulation of CCL21 Greatly Increases Its Effectiveness as an Immunotherapy for Neuroblastoma

Neuroblastoma is the most commonly diagnosed extracranial solid tumor in children. The patients with aggressive metastatic disease or refractory/relapsed neuroblastoma currently face a dismally low chance of survival. Thus, there is a great need for more effective therapies for this illness. In prev...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Control Release
Autori principali: Poelaert, Brittany J., Romanova, Svetlana, Knoche, Shelby M., Olson, Madeline T., Sliker, Bailee H., Smits, Kaitlin, Dickey, Brittney L., Moffitt-Holida, Alexandra E. J., Goetz, Benjamin T., Khan, Nuzhat, Smith, Lynette, Band, Hamid, Mohs, Aaron M., Coulter, Donald W., Bronich, Tatiana K., Solheim, Joyce C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606783/
https://ncbi.nlm.nih.gov/pubmed/32711026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2020.07.024
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi